Business - Briefly   

Wockhardt gets USFDA approval for product

NEW DELHI: Wockhardt has announced that it had received approval from the U.S. Food and Drug Administration (USFDA) for marketing Cefuroxime Axetil in the U.S. market. The company's U.S. subsidiary, Wockhardt USA, is expected to launch the cephalosporin antibiotic tablets in three strengths — 125 mg, 250 mg and 500 mg — over the next few weeks, Wockhardt said in a statement.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Sensex shoots up further by 87 points
Oracle buys 41 p.c. stake in i-flex in $600 m deal
Coal Ministry seeks nod for capacity expansion
Sun Micro to invest more
Bill for sale of GEH passed
Rupee loses 12 paise
Sri Lankan Airlines plans more flights from India
Exporters plan dharna
Stansfield Group's plans for India
India seeks to allay fears of Pakistani businessmen
China scraps export rebate for manganese
Exchange rates
Bullion rates
CNOOC withdraws bid for Unocal
SHCIL to open more branches
Subex bags order from ISP in North America
Eurotech launches Best Net KVM switches
H & M System releases new version
Peninsular opens new branches in TN and AP
Tata Teleservices launches branded mobile phone
Meenakshi (India) to expand operations
Headset compatible with Bluetooth handsets
Wockhardt gets USFDA approval for product
Bush signs Central America trade bill
Foreign directors in Indian company
Part time director on MUL board

Copyright © 2005, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu